The FirstSave STAR Biphasic AED is intended to be used by personnel who have been trained in its operation. The user should be qualified by training in basic life support or other physician-authorized emergency medical response. The device is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are unresponsive and not breathing. Post-resuscitation, if the victim is breathing, the AED should be left attached to allow for acquisition and detection of the ECG rhythm1. If a shockable ventricular tachyarrythmia recurs, the device will charge automatically and advise the operator to deliver therapy. The device is intended for use on persons older than eight years of age2.
Device Story
Portable, battery-operated, semiautomatic DC defibrillator; analyzes patient ECG via RhythmX algorithm to identify shockable rhythms; provides voice prompts and LED status indicators; operator initiates shock via single button; delivers biphasic truncated exponential waveform; used by trained personnel in emergency settings; device remains attached post-resuscitation for continuous rhythm monitoring; automatic charging if shockable rhythm recurs; benefits patient by providing rapid, automated defibrillation therapy.
Clinical Evidence
Bench testing only. Performance data includes rhythm detection accuracy, EMC, charge time, pulse shape, battery capacity, and defibrillation recovery. Environmental testing included foreign object/water penetration, drop, vibration, humidity, altitude, and temperature. Hardware and software design verification and validation performed.
Technological Characteristics
Biphasic truncated exponential waveform; lithium battery; LED diagnostic panel; non-volatile status indicator; voice prompts; RhythmX ECG analysis algorithm. Complies with AAMI DF39-1993 and IEC 601-2-4 standards.
Indications for Use
Indicated for emergency treatment of sudden cardiac arrest in patients older than eight years who are unresponsive and not breathing. Requires trained operators (basic life support or physician-authorized emergency responders).
Regulatory Classification
Identification
An automated external defibrillator (AED) system consists of an AED and those accessories necessary for the AED to detect and interpret an electrocardiogram and deliver an electrical shock (e.g., battery, pad electrode, adapter, and hardware key for pediatric use). An AED system analyzes the patient's electrocardiogram, interprets the cardiac rhythm, and automatically delivers an electrical shock (fully automated AED), or advises the user to deliver the shock (semi-automated or shock advisory AED) to treat ventricular fibrillation or pulseless ventricular tachycardia.
Predicate Devices
FirstSave STAR Biphasic AED, models 9200 and 9210 (K010214)
K982264 — FIRSTSAVE BIPHASIC MODELS 9200 AND 9210 · Survivalink Corp. · Jan 25, 1999
Submission Summary (Full Text)
{0}------------------------------------------------
# 510(k) Summary Ko 190 (
FEB 0 1 2002
#### ADMINSTRATIVE INFORMATION N-1.
### N-1.1 Name and address
| Submitted by: | Survivalink Corporation |
|---------------|-------------------------|
| | 5430 Feltl Road |
| | Minneapolis, MN 55343 |
| Contact Person: | Sew-Wah Tay, Ph.D. |
|-----------------|--------------------|
| Telephone No.: | 952-939-2942 |
| Facsimile No.: | 952-939-4191 |
June 15, 2001 Date Prepared:
## N-1.2 Device Name
Common or Usual Name: Automated External Defibrillator (AED) Device Name: FirstSave™ Automated External Defibrillator
#### Classification N-1.3
# Class III MKJ (AED)
Classification Name: a) DC defibrillator
21CFR 8870.5300; Class II
- b) Cardiac Monitor (Cardiotachometer and Rate Alarm) 21CFR \$870.2300; Class II
## N-1.4 Applicant
Applicant's Name: Survivalink, Corporation 5430 Feltl Road Minneapolis, MN 55343
#### PREDICATE DEVICES N-2.
FirstSave STAR Biphasic AED, models 9200 and 9210 (K010214), Powerheart AED (K993533)
#### INDICATION FOR USE N-3.
The FirstSave STAR Biphasic AED is intended to be used by personnel who have been trained in its operation. The user should be qualified by training in basic life support or other physician-authorized emergency medical response. The device is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are unresponsive and not breathing. Post-resuscitation, if the victim is breathing, the AED should be left attached to allow for acquisition and detection of the ECG rhythm'. If a shockable ventricular tachyarrythmia recurs, the device will charge automatically and
{1}------------------------------------------------
advise the operator to deliver therapy. The device is intended for use on persons older than eight years of age2.
- (1) American Heart Association "Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care" Circulation Supplement Vol 102(8) Aug. 2000, page I-66.
- (2) American Heart Association "Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care" Circulation Supplement Vol 102(8) Aug. 2000, page I-64.
#### DEVICE DESCRIPTION N-4
The FirstSave STAR Biphasic AED is a biphasic portable battery operated semiautomatic low power DC defibrillator. The device's diagnostic algorithm analyzes the patient's cardiac rhythm to determine shockable versus non-shockable EKG rhythm. The operator then pushes the button to deliver the defibrillation shock. The FirstSave STAR Biphasic feature includes:
- Lithium battery �
- Single user button for Rescue or Resume .
- LED diagnostic panel .
- Non-volatile status indicator .
- Voice prompts .
- Biphasic truncated exponential defibrillation waveform ●
- RhythmX ECG analysis algorithm .
#### SUBSTANTIAL EQUIVALENCE N-5.
The Company's modified FirstSave STAR Biphasic covered by this submission is substantially equivalent to other legally marketed semi-automatic low power DC defibrillators. Specifically, the FirstSave STAR Biphasic is substantially equivalent to the Survivalink FirstSave STAR Biphasic previously cleared under the 510(k) K010214. and the PowerHeart (K993533) The FirstSave STAR Biphasic has the same general indication for use, similar principles of operation, and similar technological characteristics as the previously cleared predicate devices. The differences this device and its predicate devices do not raise new questions of safety or efficacy.
#### PERFORMANCE DATA N-6.
The performance test data is provided in the 510(k) submission. The performance data demonstrate that the device complies with the applicable sections of AAMI DF39-1993, IEC 601-2-4.
Tests results include rhythm detection, EMC, charge time, pulse shape, battery capacity, defibrillation recovery, design verification and validation data for hardware and software incorporated into the FirstSave STAR Biphasic. Environmental tests performed on the finished device include foreign object and water penetration, drop, vibration, humidity, altitude and temperature.
{2}------------------------------------------------
Test data demonstrate that the safety and effectiveness of the Modified FirstSave STAR Biphasic in this submission is substantially equivalent to the predicate device.
:
{3}------------------------------------------------
Image /page/3/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services - USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the top half of the circle. In the center of the seal is an image of an eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
FEB 01 2002
Mr. John Carline Manager of Regulatory Affairs Survivalink Corporation 5420 Feltl Road Minneapolis, MN 55343
Re: K011901
Trade Name: FirstSave STAR Biphasic AED Regulation Number: 21 CFR 870.1025 Regulation Name: Automated External Defibrillator Regulatory Class: Class III (three) Product Code: MKJ Dated: October 16, 2001 Received: October 17, 2001
Dear Mr. Carline:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
{4}------------------------------------------------
## Page 2 - Mr. John Carline
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4646. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely yours,
Dola Tiller
Bram D. Zuckerman, M.D. Acting Director Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
{5}------------------------------------------------
K011901 510(k) Number:
FirstSave STAR Biphasic AED Device Name:
## Indication for Use
The FirstSave STAR Biphasic AED is intended to be used by personnel who have been trained in its operation. The user should be qualified by training in basic life support or other physician-authorized emergency medical response. The device is indicated for emergency treatment of victims exhibiting symptoms of sudden cardiac arrest who are unresponsive and not breathing. Post-resuscitation, if the victim is breathing, the AED should be left attached to allow for acquisition and detection of the ECG rhythm1. If a shockable ventricular tachyarrythmia recurs, the device will charge automatically and advise the operator to deliver therapy. The device is intended for use on persons older than eight years of age2.
- (1) American Heart Association "Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care" Circulation Supplement Vol 102(8) Aug. 2000, page I-66.
- (2) American Heart Association "Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care" Circulation Supplement Vol 102(8) Aug. 2000, page 1-64.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per 21 CFR 801.109)
OR Over-The Counter Use
Division of Cardiovascular & Respiratory Devices
510(k) Number K01/901
P-2 (Amend 1)
Panel 1
/
Sort by
Ready
Predicate graph will load when search results are available.
Embedding visualization will load when search results are available.
PDF viewer will load when search results are available.
Loading panels...
Select an item from Submissions
Click any panel, subpart, regulation, product code, or device to see details here.
Section Matches
Results will appear here.
Product Code Matches
Results will appear here.
Special Control Matches
Results will appear here.
Loading collections...
Loading
My Alerts
You will receive email notifications based on the filters and frequency you set for each alert.